Asahi Kasei Pharma Corporation

Asahi Kasei Therapeutics Corporation, formerly known as Asahi Kasei Pharma Corporation, is a specialized, research-driven pharmaceutical company operating as a core member of the Asahi Kasei Group. The company focuses on the discovery, development, and distribution of innovative therapeutic solutions, with a primary emphasis on fields including musculoskeletal disorders, pain management, immunology, urology, and critical care. By utilizing advanced drug discovery technologies and a dedicated Pharmaceuticals Research Center in Shizuoka, Japan, the company fosters an open innovation culture, collaborating with internal teams, academia, and global biopharmaceutical partners to address unmet medical needs.

The company provides significant value to patients and healthcare systems by delivering innovative treatments for complex and underserved medical conditions, such as chronic liver disease and rare disorders. Through strategic distribution partnerships and international clinical development pipelines, Asahi Kasei Therapeutics addresses critical health challenges associated with aging populations and evolving medical requirements. Their commitment to research excellence, demonstrated through a robust portfolio of development-stage drugs and marketed products, ensures that they remain a key contributor to therapeutic advancements both within Japan and in the global pharmaceutical market.